Related references
Note: Only part of the references are listed.TRIP4 promotes tumor growth and metastasis and regulates radiosensitivity of cervical cancer by activating MAPK, PI3K/AKT, and hTERT signaling
Yilin Che et al.
CANCER LETTERS (2019)
E6/E7 and E6*From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes
Cristina Artaza-Irigaray et al.
FRONTIERS IN IMMUNOLOGY (2019)
Revised FIGO staging for carcinoma of the cervix uteri
Neerja Bhatla et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2019)
Efficient leukocyte depletion by a novel microfluidic platform enables the molecular detection and characterization of circulating tumor cells
Eva Obermayr et al.
ONCOTARGET (2018)
PI3K/AKT signaling pathway involvement in fluoride-induced apoptosis in C2C12 cells
Bian-hua Zhou et al.
CHEMOSPHERE (2018)
Cell Adhesion and Matrix Stiffness: Coordinating Cancer Cell invasion and Metastasis
Vasiliki Gkretsi et al.
FRONTIERS IN ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Overview of advances in vasculogenic mimicry - a potential target for tumor therapy
Hong Ge et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity
Valentina Poltavets et al.
FRONTIERS IN ONCOLOGY (2018)
TUSC3: functional duality of a cancer gene
Katerina Vasickova et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer
Fei Ouyang et al.
ONCOLOGY REPORTS (2017)
Oncogenic function of TUSC3 in non-small cell lung cancer is associated with Hedgehog signalling pathway
Ye Gu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Phase I Dose-Escalation Study of Weekly Paclitaxel and Cisplatin Followed by Radical Hysterectomy in Stages IB2 and IIA2 Cervical Cancer
Hung-Hsueh Chou et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Acylglycerol kinase is over-expressed in early-stage cervical squamous cell cancer and predicts poor prognosis
Fei Sun et al.
TUMOR BIOLOGY (2016)
Comprehensive analysis of the long noncoding RNA HOXA11-AS gene interaction regulatory network in NSCLC cells
Yu Zhang et al.
CANCER CELL INTERNATIONAL (2016)
TUSC3 promotes colorectal cancer progression and epithelial-mesenchymal transition (EMT) through WNT/-catenin and MAPK signalling
Ye Gu et al.
JOURNAL OF PATHOLOGY (2016)
TUSC3 suppresses glioblastoma development by inhibiting Akt signaling
Zhenfeng Jiang et al.
TUMOR BIOLOGY (2016)
Quantitative detection of TUSC3 promoter methylation -a potential biomarker for prognosis in lung cancer
Uta Duppel et al.
ONCOLOGY LETTERS (2016)
Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis (vol 11, e0149028, 2016)
PLOS ONE (2016)
Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival
Fei Sun et al.
BMC CANCER (2015)
EMT in cervical cancer: Its role in tumour progression and response to therapy
Rehana Qureshi et al.
CANCER LETTERS (2015)
The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer
Seiji Mabuchi et al.
GYNECOLOGIC ONCOLOGY (2015)
Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells
Katerina Kratochvilova et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition
Wenting Xu et al.
CELL ADHESION & MIGRATION (2015)
TUSC3 Loss Alters the ER Stress Response and Accelerates Prostate Cancer Growth in vivo
Peter Horak et al.
SCIENTIFIC REPORTS (2014)
Methylation status of TUSC3 is a prognostic factor in ovarian cancer
Dietmar Pils et al.
CANCER (2013)
SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway
Yasuyuki Gen et al.
CANCER SCIENCE (2013)
Involvement of the TGF-β and β-Catenin Pathways in Pelvic Lymph Node Metastasis in Early-Stage Cervical Cancer
Maartje G. Noordhuis et al.
CLINICAL CANCER RESEARCH (2011)
A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors
J. S. W. Low et al.
ONCOGENE (2011)
Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development
Hao Zhou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mechanisms of ROS modulated cell survival during carcinogenesis
J. S. Clerkin et al.
CANCER LETTERS (2008)
Epithelial-mesenchymal transition in cervical cancer: Correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation
Mei-Yi Lee et al.
CLINICAL CANCER RESEARCH (2008)
Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma -: N33 and EFA6R have a potential impact on overall survival
D Pils et al.
CANCER (2005)
Share Paper
